Description
Market Report Coverage – Capillary Electrophoresis
Market Segmentation
• By Product Type – Instrument, Consumables, and Software
• By Mode – Capillary Gel Electrophoresis (CGE), Capillary Zone Electrophoresis (CZE), Capillary Electro Chromatography (CEC), and Other Mode
• By Application – Nucleic Acid Analysis and Protein Analysis
• By End User – Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User
Regional Segmentation
• North America: U.S., Canada
• Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe
• Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America: Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World
Market Growth Drivers
• Strategic Initiatives by Key Market Players
• Increasing Adoption of Sequencing in Various Research Fields
• Increase in Adoption of Personalized Medicine
Market Challenges
• Lack of Infrastructure and Expertise
• High Capital Requirement Hampering the Expansion of Global Reach
• Uncertain Reimbursement Scenario
Market Opportunities
• Government and Private Support for Capillary Electrophoresis on a Large Scale
• Novel Diagnostic Applications
Key Companies Profiled
QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher, Bio-Techne, PerkinElmer Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, Helena Laboratories, BiOptic Inc., LABGENE Scientific SA, Hitachi Ltd., Teledyne Technologies Incorporated
Key Questions Answered in this Report:
• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Product type (instrument, consumables, and software)
o Mode (capillary gel electrophoresis, capillary zone electrophoresis, and capillary electro chromatography)
o Applications (nucleic acid analysis and protein analysis)
o End user (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end users)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the major market drivers, challenges, and opportunities in the global capillary electrophoresis market?
• What are the underlying structures resulting in the emerging trends within the global capillary electrophoresis market?
• How is each segment of the global capillary electrophoresis market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
• What are the key developmental strategies implemented by the major players to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for capillary electrophoresis?
• Who are the leading players with significant offerings to the global capillary electrophoresis market? What is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which capillary electrophoresis product type is anticipated to have the most promising growth?
• What are the key applications in the global capillary electrophoresis market? What are the major segments of these applications? What technologies are dominating these application segments?
• What are the major technologies that are employed in the global capillary electrophoresis market? Which is the dominating technology?
• Who are the primary end users of the global capillary electrophoresis market? Which is the fastest-growing end-use segment in the global capillary electrophoresis market?
• Who are the key manufacturers in the global capillary electrophoresis market, and what are their contributions? Also, what is the growth potential of each major capillary electrophoresis manufacturer?
• What is the scope of the global capillary electrophoresis market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which capillary electrophoresis application and end user dominate these regions?
• What are the emerging trends in the global capillary electrophoresis market? How are these trends revolutionizing the diagnostic procedure?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the regulatory procedures that are required to unify the approval process for emerging capillary electrophoresis? How will these enhance the reimbursement scenario?
• What are the gaps in regularizing optimum capillary electrophoresis adoption in regular healthcare routines? How are these gaps being tackled?
Market Overview
Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy and is broadly used for nucleic acid analysis and protein analysis applications.
Our healthcare experts have found the capillary electrophoresis market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031.
Factors fueling the growth of the market include strategic initiatives by key market players and increasing adoption of sequencing in various research fields increase in adoption of personalized medicine; despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. Lack of infrastructure and expertise high capital requirement hampering the expansion of global reach uncertain reimbursement scenario further, some of the opportunities, such as government and private support for capillary electrophoresis on large-scale novel diagnostic applications, provide growth to the market.
Within the research report, the market has been segmented on the basis of product type, mode, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the prevalence of infectious diseases and various types of cancer on the global level has created a buzz among companies to invest in advanced technologies such as molecular diagnostics.
Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.
Table of Contents
1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion
2 Scope of the Study
2.1 Key Questions Answered in the Report
3 Research Methodology
3.1 Data Source
3.1.1 Primary Data Source
3.1.1.1 Primary Research Methodology
3.1.2 Secondary Data Sources
3.1.2.1 Open Sources
3.2 Market Estimation Model
3.2.1 Criteria for Company Profiling
4 Market Overview
4.1 Emerging Applications of Capillary Electrophoresis
4.2 Addressable Market Size and Growth Potential
4.3 COVID-19 Impact on Global Capillary Electrophoresis Market
4.3.1 Impact on Market Size
4.4 Competitive Landscape
4.5 Corporate Strategies
4.5.1 Synergistic Activities
4.5.2 Acquisitions
4.5.3 Business Expansion
4.6 Business Strategies
4.6.1 Product Launches
4.7 Market Share Analysis (by Company)
4.8 Growth Share Analysis (by Company)
4.9 Industry Analysis
4.9.1 Legal Requirements and Framework in the U.S.
4.9.2 FDA Regulations
4.9.3 Legal Requirements and Framework in Europe
4.9.3.1 U.K.
4.9.3.2 Germany
4.1 Legal Requirements and Framework in Asia-Pacific
4.10.1.1 China
4.10.1.2 Japan
4.10.1.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
4.11 Market Dynamics
4.12 Impact Analysis
4.13 Market Drivers
4.13.1 Strategic Initiatives by Key Market Players
4.13.2 Increasing Adoption of Sequencing in Various Research Fields
4.13.3 Increase in Adoption of Personalized Medicine
4.14 Market Restraints
4.14.1 Lack of Infrastructure and Expertise
4.14.2 High Capital Requirement Hampering the Expansion of Global Reach
4.14.3 Uncertain Reimbursement Scenario
4.15 Opportunities
4.15.1 Government and Private Support for Capillary Electrophoresis on a Large Scale
4.15.2 Novel Diagnostic Applications
5 Global Capillary Electrophoresis Market, by Products Type, $Million, 2020-2031
5.1 Overview
5.1.1 Instrument
5.1.2 Consumables
5.1.2.1 Kits
5.1.2.2 Reagents
5.1.2.3 Other Consumables
5.1.3 Software
6 Global Capillary Electrophoresis Market, by Mode, $Million, 2020-2031
6.1 Overview
6.2 Capillary Gel Electrophoresis (CGE)
6.2.1 Capillary Zone Electrophoresis (CZE)
6.2.2 Capillary Electro Chromatography (CEC)
6.2.3 Other Mode
7 Global Capillary Electrophoresis Market, by Application, $Million, 2020-2031
7.1 Overview
7.1.1 Nucleic Acid Analysis
7.1.1.1 DNA Fragment Analysis
7.1.1.1.1 SNP Genotyping
7.1.1.1.2 Gene Editing
7.1.1.1.3 Others
7.1.1.2 RNA/mRNA Analysis
7.1.2 Protein Analysis
8 Global Capillary Electrophoresis Market, by End User, $Million, 2020-2031
8.1 Overview
8.1.1 Academic and Research Institutions
8.1.2 Clinical Laboratories
8.1.3 Pharmaceutical and Biotechnology Companies
8.1.4 Other End User
9 Global Capillary Electrophoresis Market, by Region, $Million, 2020-2031
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Switzerland
9.3.7 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest-of-Asia-Pacific
9.5 Latin America (LATAM)
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World (RoW)
10 Markets - Competitive Benchmarking & Company Profiles
10.1 Overview
10.2 QIAGEN
10.2.1 Company Overview
10.2.2 Role of QIAGEN in the Global Capillary Electrophoresis Market
10.2.3 Key Customers of the Company
10.2.4 Key Competitors of the Company
10.2.5 Financials
10.2.6 Key Insights About Financial Health of the Company
10.2.7 SWOT Analysis
10.3 Thermo Fisher Scientific Inc.
10.3.1 Company Overview
10.3.2 Role of Thermo Fisher Scientific Inc. in the Global Capillary Electrophoresis Market
10.3.3 Key Customers of the Company
10.3.4 Key Competitors of the Company
10.3.5 Financials
10.3.6 Key Insights About Financial Health of the Company
10.3.7 SWOT Analysis
10.4 Agilent Technologies, Inc.
10.4.1 Company Overview
10.4.2 Role of Agilent Technologies, Inc. in the Global Capillary Electrophoresis Market
10.4.3 Key Customers of the Company
10.4.4 Key Competitors of the Company
10.4.5 Financials
10.4.6 Key Insights About Financial of the Company
10.4.7 SWOT Analysis
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Company Overview
10.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Capillary Electrophoresis Market
10.5.3 Key Customers of the Company
10.5.4 Key Competitors of the Company
10.5.5 Financials
10.5.6 Key Insights About Financial Health of the Company
10.5.7 SWOT Analysis
10.6 Danaher
10.6.1 Company Overview
10.6.2 Role of Danaher in the Global Capillary Electrophoresis Market
10.6.3 Key Customers of the Company
10.6.4 Key Competitors of the Company
10.6.5 Financials
10.6.6 Key Insights About Financial Health of the Company
10.6.7 SWOT Analysis
10.7 Bio-Techne
10.7.1 Company Overview
10.7.2 Role of Bio-Techne in the Global Capillary Electrophoresis Market
10.7.3 Key Customers of the Company
10.7.4 Key Competitors of the Company
10.7.5 Financials
10.7.6 Key Insights About Financial Health of the Company
10.7.7 SWOT Analysis
10.8 PerkinElmer Inc.
10.8.1 Company Overview
10.8.2 Role of PerkinElmer Inc. in the Global Capillary Electrophoresis Market
10.8.3 Key Customers of the Company
10.8.4 Key Competitors of the Company
10.8.5 Financials
10.8.6 Key Insights About Financial Health of the Company
10.8.7 SWOT Analysis
10.9 Merck KGaA
10.9.1 Company Overview
10.9.2 Role of Merck KGaA in the Global Capillary Electrophoresis Market
10.9.3 20.3 Key Customers of the Company
10.9.4 Key Competitors of the Company
10.9.5 Financials
10.9.6 Key Insights About Financial Health of the Company
10.9.7 SWOT Analysis
10.1 Promega Corporation
10.10.1 Company Overview
10.10.2 Role of Promega Corporation in the Global Capillary Electrophoresis Market
10.10.3 Key Customers of the Company
10.10.4 Key Competitors of the Company
10.10.5 SWOT Analysis
10.11 Shimadzu Corporation
10.11.1 Company Overview
10.11.2 Role of Shimadzu Corporation in the Global Capillary Electrophoresis Market
10.11.3 Key Customers of the Company
10.11.4 Key Competitors of the Company
10.11.5 Financials
10.11.6 Key Insights About Financial Health of the Company
10.11.7 SWOT Analysis
10.12 Helena Laboratories
10.12.1 Company Overview
10.12.2 Role of Helena Laboratories in the Global Capillary Electrophoresis Market
10.12.3 Key Customers of the Company
10.12.4 Key Competitors of the Company
10.12.5 SWOT Analysis
10.13 BiOptic Inc.
10.13.1 Company Overview
10.13.2 Role of BiOptic Inc. in the Global Capillary Electrophoresis Market
10.13.3 Key Customers of the Company
10.13.4 Key Competitors of the Company
10.13.5 SWOT Analysis
10.14 LABGENE Scientific SA
10.14.1 Company Overview
10.14.2 Role of LABGENE Scientific SA in the Global Capillary Electrophoresis Market
10.14.3 Key Customers of the Company
10.14.4 Key Competitors of the Company
10.14.5 SWOT Analysis
10.15 Hitachi Ltd.
10.15.1 Company Overview
10.15.2 Role of Hitachi Ltd. in the Global Capillary Electrophoresis Market
10.15.3 Key Customers of the Company
10.15.4 Key Competitors of the Company
10.15.5 Financials
10.15.6 Key Insights About Financial Health of the Company
10.15.7 SWOT Analysis
10.16 Teledyne Technologies Incorporated
10.16.1 Company Overview
10.16.2 Role of Teledyne Technologies Incorporated in the Global Capillary Electrophoresis Market
10.16.3 Key Customers of the Company
10.16.4 Key Competitors of the Company
10.16.5 Financials
10.16.6 SWOT Analysis
List of Figures
Figure 1: Annual NIH Funding in Human Genomics Research, $Billion, FY2013-FY2020
Figure 2: Global Capillary Electrophoresis Market Dynamics
Figure 3: Share of Key Market Strategies and Developments, February 2018-December 2021
Figure 4: Global Capillary Electrophoresis Market Snapshot, $Million, 2020-2031
Figure 5: Global Capillary Electrophoresis Market (by Product Type), $Million, 2020 Vs. 2031
Figure 6: Global Capillary Electrophoresis Market (by Mode), $Million, 2020 Vs. 2031
Figure 7: Global Capillary Electrophoresis Market (by Application), $Million, 2020 Vs. 2031
Figure 8: Global Capillary Electrophoresis Market (by End User), $Million, 2020 Vs. 2031
Figure 9: Global Capillary Electrophoresis Market (by Region), $Million, 2020 Vs. 2031
Figure 10: Global Capillary Electrophoresis Market: Segmentation
Figure 11: Global Capillary Electrophoresis Market Research Methodology
Figure 12: Global Capillary Electrophoresis Market, $Million, 2020-2031
Figure 13: Pre-COVID-19 and Post-COVID-19 Scenario of Global Capillary Electrophoresis Market, 2019-2026
Figure 14: Impact of COVID-19 on Capillary Electrophoresis Market
Figure 15: Share of Key Developments and Strategies, January 2018-December 2021
Figure 16: Share of Synergistic Activities (by Company), September 2020-November 2021
Figure 17: Share of Acquisition (by Company), March 2018-December 2021
Figure 18: Share of Business Expansion (by Company), February 2018-June 2021
Figure 19: Share of Product Launches (by Company), July 2018-September 2021
Figure 20: Market Share Analysis for Global Capillary Electrophoresis Market, $Million, 2019 and 2020
Figure 21: Growth Share Analysis of Global Capillary Electrophoresis Market (by Company), 2019-2020
Figure 22: Responsibilities of the National Medical Products Administration (NMPA)
Figure 23: Global Capillary Electrophoresis Market Dynamics
Figure 24: Global Capillary Electrophoresis Market (by Product Type), $Million, 2020 and 2031
Figure 25: Global Capillary Electrophoresis Market (Instruments), $Million, 2020-2031
Figure 26: Global Capillary Electrophoresis Market (Instruments), Thousand Units, 2021-2031
Figure 27: Global Capillary Electrophoresis Market (Consumables), $Million, 2020-2031
Figure 28: Global Capillary Electrophoresis Market (Kits), $Million, 2020-2031
Figure 29: Global Capillary Electrophoresis Market (Kits), Thousand Units, 2021-2031
Figure 30: Global Capillary Electrophoresis Market (Reagents), $Million, 2020-2031
Figure 31: Global Capillary Electrophoresis Market (Other Consumables), $Million, 2020-2031
Figure 32: Global Capillary Electrophoresis Market (Software), $Million, 2020-2031
Figure 33: Share of Global Capillary Electrophoresis Market (by Mode), $Million, 2020 and 2031
Figure 34: Global Capillary Electrophoresis Market (Capillary Gel Electrophoresis), $Million, 2020-2031
Figure 35: Global Capillary Electrophoresis Market (Capillary Zone Electrophoresis), $Million, 2020-2031
Figure 36: Global Capillary Electrophoresis Market (Capillary Electro Chromatography), $Million, 2020-2031
Figure 37: Global Capillary Electrophoresis Market (Other Mode), $Million, 2020-2031
Figure 38: Share of Global Capillary Electrophoresis Market (by Application), $Million, 2020 and 2031
Figure 39: Global Capillary Electrophoresis Market (Nucleic Acid Analysis), $Million, 2021-2031
Figure 40: Global Capillary Electrophoresis Market (DNA Fragment Analysis), $Million, 2020-2031
Figure 41: Global Capillary Electrophoresis Market (SNP Genotyping), $Million, 2020-2031
Figure 42: Global Capillary Electrophoresis Market (Gene Editing), $Million, 2020-2031
Figure 43: Global Capillary Electrophoresis Market (Others), $Million, 2021-2031
Figure 44: Global Capillary Electrophoresis Market (RNA/mRNA Analysis), $Million, 2021-2031
Figure 45: Global Capillary Electrophoresis Market (Protein Analysis), $Million, 2020-2031
Figure 46: Share of Global Capillary Electrophoresis Market (by End User), $Million, 2020 and 2031
Figure 47: Global Capillary Electrophoresis Market (Academic and Research Institutions), $Million, 2020-2031
Figure 48: Global Capillary Electrophoresis Market (Clinical Laboratories), $Million, 2020-2031
Figure 49: Global Capillary Electrophoresis Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
Figure 50: Global Capillary Electrophoresis Market (Other End User), $Million, 2020-2031
Figure 51: Global Capillary Electrophoresis Market (by Region), $Million, 2020-2031
Figure 52: Share of North America Capillary Electrophoresis Market Revenue (by Country), $Million, 2020 and 2031
Figure 53: North America: Market Dynamics
Figure 54: U.S. Capillary Electrophoresis Market, $Million, 2020-2031
Figure 55: Canada Capillary Electrophoresis Market, $Million, 2020-2031
Figure 56: Europe Capillary Electrophoresis Market (by Country), $Million, 2020 and 2031
Figure 57: Europe: Market Dynamics
Figure 58: Germany Capillary Electrophoresis Market, $Million, 2020-2031
Figure 59: U.K. Capillary Electrophoresis Market, Million, 2020-2031
Figure 60: France Capillary Electrophoresis Market, $Million, 2020-2031
Figure 61: Italy Capillary Electrophoresis Market, $Million, 2020-2031
Figure 62: Spain Capillary Electrophoresis Market, Million, 2020-2031
Figure 63: Switzerland Capillary Electrophoresis Market, Million, 2020-2031
Figure 64: Rest-of-Europe Capillary Electrophoresis Market, Million, 2020-2031
Figure 65: APAC: Market Dynamics
Figure 66: Asia-Pacific Capillary Electrophoresis Market (by Country), $Million, 2020 and 2031
Figure 67: China Capillary Electrophoresis Market, $Million, 2020-2031
Figure 68: India Capillary Electrophoresis Market, $Million, 2020-2031
Figure 69: Japan Capillary Electrophoresis Market, $Million, 2020-2031
Figure 70: Australia Capillary Electrophoresis Market, Million, 2020-2031
Figure 71: South Korea Capillary Electrophoresis Market, Million, 2020-2031
Figure 72: Rest-of-Asia-Pacific Capillary Electrophoresis Market, $Million, 2020-2031
Figure 73: LATAM: Market Dynamics
Figure 74: Latin America Capillary Electrophoresis Market (by Country), $Million 2020-2031,
Figure 75: Brazil Capillary Electrophoresis Market, $Million, 2020-2031
Figure 76: Mexico Capillary Electrophoresis Market, Million, 2020-2031
Figure 77: Rest-of-Latin America Capillary Electrophoresis Market, $Million, 2020-2031
Figure 78: Rest-of-the-World Capillary Electrophoresis Market, $Million, 2020-2031
Figure 79: Share of Key Company Profiles
Figure 80: QIAGEN: Overall Product Portfolio
Figure 81: QIAGEN: Overall Financials, $Million, 2018-2020
Figure 82: QIAGEN: Revenue (by Segment), $Million, 2018-2020
Figure 83: QIAGEN: Revenue (by Region), $Million, 2018-2020
Figure 84: QIAGEN: R&D Expenditure, $Million, 2018-2020
Figure 85: QIAGEN: SWOT Analysis
Figure 86: Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 87: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 88: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 89: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020
Figure 90: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 91: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 92: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 93: Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 94: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 95: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 96: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 97: Agilent Technologies, Inc.: SWOT Analysis
Figure 98: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
Figure 99: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
Figure 100: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2018-2020
Figure 101: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2018-2020
Figure 102: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
Figure 103: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 104: Danaher: Overall Product Portfolio
Figure 105: Danaher: Overall Financials, 2018-2020
Figure 106: Danaher: Revenue (by Segment), 2018-2020
Figure 107: Danaher: Revenue (by Region), 2018-2020
Figure 108: Danaher: R&D Expenditure, 2018-2020
Figure 109: Danaher: SWOT Analysis
Figure 110: Bio-Techne: Product Portfolio
Figure 111: Bio-Techne: Overall Financials, 2018-2020
Figure 112: Bio-Techne Revenue (by Segment), 2018-2020
Figure 113: Bio-Techne.: Revenue (by Region), 2018-2020
Figure 114: Bio-Techne: R&D Expenditure, 2018-2020
Figure 115: Bio-Techne: SWOT Analysis
Figure 116: PerkinElmer Inc.: Product Portfolio
Figure 117: PerkinElmer Inc.: Overall Financials, 2018-2020
Figure 118: PerkinElmer Inc.: Revenue (by Segment), 2018-2020
Figure 119: PerkinElmer Inc: Revenue (by Region), 2018-2020
Figure 120: PerkinElmer Inc.: R&D Expenditure, 2018-2020
Figure 121: PerkinElmer Inc.: SWOT Analysis
Figure 122: Merck KGaA: Product Portfolio
Figure 123: Merck KGaA: Overall Financials, 2018-2020
Figure 124: Merck KGaA: Revenue (by Segment), 2018-2020
Figure 125: Merck KGaA: Revenue (by Region), 2018-2020
Figure 126: Merck KgaA: R&D Expenditure, 2018-2020
Figure 127: Merck KGaA: SWOT Analysis
Figure 128: Promega Corporation.: Product Portfolio
Figure 129: Promega Corporation: SWOT Analysis
Figure 130: Shimadzu Corporation: Product Portfolio
Figure 131: Shimadzu Corporation: Overall Financials, 2018-2020
Figure 132: Shimadzu Corporation: Revenue (by Segment), 2018-2020
Figure 133: Shimadzu Corporation: Revenue (by Region), 2018-2020
Figure 134: Shimadzu Corporation: R&D Expenditure, 2018-2020
Figure 135: Shimadzu Corporation: SWOT Analysis
Figure 136: Helena Laboratories: Product Portfolio
Figure 137: Helena Laboratories: SWOT Analysis
Figure 138: BiOptic Inc.: Product Portfolio
Figure 139: BiOptic Inc.: SWOT Analysis
Figure 140: LABGENE Scientific SA: Product Portfolio
Figure 141: LABGENE Scientific SA: SWOT Analysis
Figure 142: Hitachi Ltd.: Product Portfolio
Figure 143: Hitachi Ltd.: Overall Financials, 2018-2020
Figure 144: Hitachi Ltd.: Revenue (by Segment), 2018-2020
Figure 145: Hitachi Ltd.: Revenue (by Region), 2018-2020
Figure 146: Hitachi Ltd.: R&D Expenditure, 2018-2020
Figure 147: Hitachi Ltd.: SWOT Analysis
Figure 148: Teledyne Technologies Incorporated: Product Portfolio
Figure 149: Teledyne Technologies Incorporated: Overall Financials, 2018-2020
Figure 150: Teledyne Technologies Incorporated: Revenue (by Segment), 2018-2020
Figure 151: Teledyne Technologies Incorporated: Revenue (by Region), 2018-2020
Figure 152: Teledyne Technologies Incorporated: SWOT Analysis
List of Tables
Table 1: COVID-19 Impact on Global Capillary Electrophoresis Market
Table 2: Products Launched by Various Manufacturers for Capillary Electrophoresis Research
Table 3: Stratergic Initative by Key Market Players
Table 4: Adoption of Sequencing in Various Research Fields
Table 5: Adoption of Personalized Medicine
Table 6: Cost of Capillary Electrophoresis Products
Table 7: Government and Private Support for Capillary Electrophoresis products
Table 8: Novel Diagnostic Applications
Table 9: List of Instruments
Table 10: List of Consumables
Table 11: List of Software
Companies Mentioned
QIAGEN
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher
Bio-Techne
PerkinElmer Inc.
Merck KGaA
Promega Corporation
Shimadzu Corporation
Helena Laboratories
BiOptic Inc.
LABGENE Scientific SA
Hitachi Ltd.
Teledyne Technologies Incorporated
Reviews
There are no reviews yet.